Thursday, Jun 29 2017 | Time 00:53 Hrs(IST)
  • Van Niekerk breaks another Johnson world record in rare 300m race
  • Opposition Labour loses vote on UK austerity, pay cap
  • US to unveil enhanced airline security plan to avoid laptop ban
  • Venezuela hunts rogue helicopter attackers, Maduro foes suspicious
  • Despite healthcare hit, Trump says big surprise on bill could come
  • Brazil's Supreme Court sends Temer charges to lower house
Science & Technology Share

MedGenome launches liquid biopsy blood test 'Oncotrack' for cancer detection in patients

MedGenome launches liquid biopsy blood test 'Oncotrack' for  cancer detection in patients

Mumbai, Mar 8 (UNI) MedGenome, the country's premier Genomics-based research and diagnostics company, has launched 'Oncotrack', the liquid biopsy blood test, for cancer recurrence detection and monitoring.
The Oncotrack is a non-invasive screening test that is set to transform the way physicians in India can identify genetic alterations, interpret, assess and treat various forms of cancers.
Launching the blood test yesterday, Chief operation officer of MedGenome, Dr V L Ramprasad said, 'Liquid biopsy has the capacity to interpret infinite mutations which will pave the way for new drug discovery, research and therapies.
Over 35 oncologists in India have already screened patients using our Oncotrack.
Further, since it has a very patient-friendly approach, we are confident it will be very well accepted by both the doctors and patients.
' India is likely to have over 1.
73 million new cases of cancer and over 8,80,000 deaths due to the disease by 2020.
Around 70 per cent of all cancer patients approach the doctor when the disease has advanced, and the chances of cure are very low.
'Management of cancer will undergo a massive transformation in India with NGS-based liquid biopsies.
We are constantly striving to get the most advanced genetic testing technology/ technique at affordable prices to the patients and Oncotrack is one such offering,' said Sam Santhosh, chairman, MedGenome.
The test, developed entirely by MedGenome, is the only one to be validated in India and verified from samples of cancer patients from across the country.
The test screens the samples by analyzing cell-free DNA that is isolated from the patients’ blood.
Using high-end sequencing technology, the screening process identifies specific gene mutations that are linked with Melanoma, Lung and Colon cancers.
The test facilitates detection of mutation where there is difficulty of obtaining biopsy or in the event of a damaged biopsy material and non-availability of tissue biopsy.
This offers oncologists the power to look for actionable alterations in a patient's treatment, management, without having to do an invasive biopsy or where biopsy is not an option.
Oncotrack is a proven molecular tool after histopathology diagnosis and detecting molecular changes at baseline and at the time of relapse in lung and colon cancer for deciding the right treatment.
The test has been validated in a scientific study, in academic collaboration with Tata Memorial Hospital -- Dr Kumar Prabhash, medical oncologist, and Dr Amit Dutt, principal investigator (Scientist F) at ACTREC, Tata Memorial Centre.


Chandrayan mission discovers new group of suprathermal protons

By CNR Vijaykumar Bengaluru, Jun 28 (UNI) A new group of suprathermal protons has been discovered near the Moon by the Sub-keV Atom Reflecting Analyzer (SARA) experiment on Chandrayaan-1 - the first Indian lunar mission.


Japan Tobacco tries to catch up with rival in smokeless tobacco

TOKYO, Jun 28 (Reuters) Japan Tobacco Inc said today it hoped to catch up with Philip Morris International Inc in smokeless tobacco by expanding the number of smoke-free restaurants and public places that allow its vaping product.


Namibia bans poultry imports from South Africa, Belgium after bird flu outbreaks

WINDHOEK, Jun 27 (Reuters) Namibia has suspended poultry imports from South Africa and Belgium with immediate effect following outbreaks of highly contagious H5N8 bird flu in the two countries, its Directorate of Veterinary Services (DVS) said today.


Sun Pharma, NIV ink pact to fight Zika, Chikungunya and Dengue

Mumbai, Jun 27 (UNI) Sun Pharmaceutical Industries and The National Institute of Virology (NIV), Pune, an institution of the Indian Council of Medical Research, Department of Health Research, Ministry of Health and Family Welfare, New Delhi today announced that they have signed an agreement for testing phytopharmaceutical, biologic and chemical entities developed by Sun Pharma against Zika, Chikungunya and Dengue viruses.


Non-communicable diseases kill 40-million people each year

New Delhi, Jun 25 (UNI) Non-communicable diseases (NCDs) kill 40-million people each year, says World Health Organisation (WHO).

Broken pebbles offer clues to Palaeolithic funeral rituals

Broken pebbles offer clues to Palaeolithic funeral rituals

New Delhi, Feb 9 (UNI) Humans may have ritualistically "killed" objects to remove their symbolic power, some 5,000 years earlier than previously thought, a new international study of marine pebble tools from an Upper Palaeolithic burial site in Italy suggests.